Bronchopulmonary dysplasia: An update

被引:30
作者
Bhandari, Anita
Bhandari, Vineet
机构
[1] Yale Univ, Sch Med, Dept Pediat, Div Perinatal Med, New Haven, CT 06520 USA
[2] Connecticut Childrens Med Ctr, Div Pediat Pulmonol, Hartford, CT USA
[3] Yale Univ, Sch Med, Div Perinatal Med, New Haven, CT USA
关键词
BPD; prematurity; chronic lung disease;
D O I
10.1007/s12098-007-0032-z
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Bronchopulmonary dysplasia (BPD) is a chronic lung disease associated with premature birth and characterized by early lung injury. Over the past 4 decades, there have been significant changes in its definition, pathology and radiological findings as well as management of BPD. Management of the acute phase and later stages of this lung disease continue to evolve. Use of non-invasive ventilatory techniques, recombinant human SOD and CC10 and inhaled NO are some novel approaches that are being studied. Adequate nutrition is vital to optimize lung growth and repair. The widely accepted practice of prophylaxis against viral infections has markedly decreased the rates of rehospitalization. Infants with BPD, however, continue to have significant pulmonary and neurodevelopmental sequelae. Unraveling the genetic contribution to BPD will potentially pave the way to improved preventive and therapeutic approaches.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 42 条
[1]  
[Anonymous], 2004, COCHRANE DATABASE SY
[2]   High-resolution inspiratory and expiratory CT in older children and adults with bronchopulmonary dysplasia [J].
Aquino, SL ;
Schechter, MS ;
Chiles, C ;
Ablin, DS ;
Chipps, B ;
Webb, WR .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 173 (04) :963-967
[3]   Pulmonary function until two years of life in infants with bronchopulmonary dysplasia [J].
Baraldi, E ;
Filippone, M ;
Trevisanuto, D ;
Zanardo, V ;
Zacchello, F .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (01) :149-155
[4]   Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants [J].
Bhandari, A ;
Bhandari, V .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 :E370-E380
[5]   Potential biochemical growth markers in premature infants [J].
Bhandari, V ;
Fall, P ;
Raisz, L ;
Rowe, J .
AMERICAN JOURNAL OF PERINATOLOGY, 1999, 16 (07) :339-349
[6]   Improved outcome of extremely low birth weight infants with Tegaderm® application to skin [J].
Bhandari V. ;
Brodsky N. ;
Porat R. .
Journal of Perinatology, 2005, 25 (4) :276-281
[7]   Familial and genetic susceptibility to major neonatal morbidities in preterm twins [J].
Bhandari, Vineet ;
Bizzarro, Matthew J. ;
Shetty, Anupama ;
Zhong, Xiaoyun ;
Page, Grier P. ;
Zhang, Heping ;
Ment, Laura R. ;
Gruen, Jeffrey R. .
PEDIATRICS, 2006, 117 (06) :1901-1906
[8]  
Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8
[9]   Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome [J].
Davis, JM ;
Rosenfeld, WN ;
Richter, SE ;
Parad, R ;
Gewolb, IH ;
Spitzer, AR ;
Carlo, WA ;
Couser, RJ ;
Price, A ;
Flaster, E ;
Kassem, N ;
Edwards, L ;
Tierney, J ;
Horowitz, S .
PEDIATRICS, 1997, 100 (01) :24-30
[10]   Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase [J].
Davis, JM ;
Parad, RB ;
Michele, T ;
Allred, E ;
Price, A ;
Rosenfeld, W .
PEDIATRICS, 2003, 111 (03) :469-476